OFSA3 Stock Overview
Ouro Fino Saúde Animal Participações S.A., together with its subsidiaries, operates in the animal health industry primarily in Brazil.
No risks detected for OFSA3 from our risk checks.
Ouro Fino Saúde Animal Participações S.A. Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||R$22.11|
|52 Week High||R$32.95|
|52 Week Low||R$19.32|
|1 Month Change||9.73%|
|3 Month Change||2.60%|
|1 Year Change||-31.12%|
|3 Year Change||-44.73%|
|5 Year Change||-18.11%|
|Change since IPO||-20.04%|
Recent News & Updates
These 4 Measures Indicate That Ouro Fino Saúde Animal Participações (BVMF:OFSA3) Is Using Debt Reasonably Well
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
|OFSA3||BR Pharmaceuticals||BR Market|
Return vs Industry: OFSA3 underperformed the BR Pharmaceuticals industry which returned 9.9% over the past year.
Return vs Market: OFSA3 underperformed the BR Market which returned -20.7% over the past year.
|OFSA3 Average Weekly Movement||4.3%|
|Pharmaceuticals Industry Average Movement||6.4%|
|Market Average Movement||5.9%|
|10% most volatile stocks in BR Market||9.5%|
|10% least volatile stocks in BR Market||2.3%|
Stable Share Price: OFSA3 is not significantly more volatile than the rest of BR stocks over the past 3 months, typically moving +/- 4% a week.
Volatility Over Time: OFSA3's weekly volatility (4%) has been stable over the past year.
About the Company
|1987||17,952||Kleber Cesar Gomes||https://www.ourofinosaudeanimal.com|
Ouro Fino Saúde Animal Participações S.A., together with its subsidiaries, operates in the animal health industry primarily in Brazil. The company operates through Production Animals, Companion Animals, and International Operations segments. It manufactures and trades in medicines, including anti-inflammatories, antibiotics, anticoccidials, antimastitics, ectoparasiticides, endectocides, endoparasiticides, hemoparasiticides, inoculants, therapeutics, products for animal reproduction, and vaccines; and other veterinary products for cattle, swine, poultry, sheep, horses, and goats.
Ouro Fino Saúde Animal Participações S.A. Fundamentals Summary
|OFSA3 fundamental statistics|
Is OFSA3 overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|OFSA3 income statement (TTM)|
|Cost of Revenue||R$478.20m|
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
Nov 10, 2022
|Earnings per share (EPS)||2.08|
|Net Profit Margin||11.88%|
How did OFSA3 perform over the long term?See historical performance and comparison